“…The transgender population is a medically underserved and largely understudied population with extensive barriers to health care. Significant stigma, violence, mental health disorders, elevated human immunodeficiency virus (HIV), sexually transmitted infections (STI), and comorbidities that are indicators of suboptimal health care have been well documented among transgender persons in general, and among transgender women of color (TWC) in particular (Adelson, Dowshen, Makadon, & Garofalo, ; Ayala & Ibanez, ; Baral et al, ; Bradford, Reisner, Honnold, & Xavier, ; Brennan et al, ; Bry, Mustanski, Garofalo, & Burns, ; Cicero, Reisner, Silva, Merwin, & Humphreys, ; Eaton, Kalichman, et al, ; Eaton, Matthews, et al, ; Frank et al, ; Garofalo, Deleon, Osmer, Doll, & Harper, ; Jin et al, ; Kussin‐Shoptaw, Fletcher, & Reback, ; MacCarthy et al, ; Poteat, Wirtz, & Reisner, ; Reisner et al, ; Siembida, Eaton, Maksut, Driffin, & Baldwin, ). TWC (for the purposes of this study, we considered TWC as transgender women who identify as African‐American, Native American, Latina, Asian Pacific Islander, and/or mixed race/ethnicity) often experience compounded risks to health care that may result from prejudices associated with gender identity, poverty, racism, and heterosexism and often result in structural barriers to care (Adelson et al, ; Eaton, Kalichman, et al, ; Eaton, Matthews, et al, ; Nuttbrock, ; Nuttbrock et al, ).…”